Filing Details

Accession Number:
0000899866-18-000102
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-06-12 16:51:25
Reporting Period:
2018-06-08
Accepted Time:
2018-06-12 16:51:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
899866 Alexion Pharmaceuticals Inc ALXN Pharmaceutical Preparations (2834) 133648318
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1546216 Brian Goff C/O Alexion Pharmaceuticals, Inc.
100 College Street
New Haven CT 06510
Evp & Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $.0001 Per Share Disposition 2018-06-08 1,645 $118.53 36,257 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units.